Skip to main content
Clinical Trials/NCT02193516
NCT02193516
Unknown
Not Applicable

Identification of Corticomedullary Differentiation Along Different Stage of Pregnancy

Meir Medical Center1 site in 1 country330 target enrollmentJuly 2014
ConditionsNephropathy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Nephropathy
Sponsor
Meir Medical Center
Enrollment
330
Locations
1
Primary Endpoint
CMD presence
Last Updated
11 years ago

Overview

Brief Summary

Corticomedullary differentiation (CMD) abnormality (absent/reversed) is a parameter that can indicate possible nephropathy. The evolution of CMD across gestation had not been well established. Devrendt et al demonstrated the presence of CMD in all fetuses older then 20 weeks. In our study we would like to determine the exact timing of it's sonographic visualisation. This is a prospective study recruiting women between 14-24 week gestation during routine ultrasound screening. A midsagittal image of each kidney will be taken by a single sonographer and examined for the presence of the CMD by two other sonographers blinded to gestational age.

Registry
clinicaltrials.gov
Start Date
July 2014
End Date
June 2015
Last Updated
11 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • pregnant women 14-24 weeks
  • singleton pregnancy
  • Appropriate for gestational age fetuses
  • well dated pregnancy

Exclusion Criteria

  • family history of renal disease
  • small /large for gestational age fetuses
  • known structural anomalies
  • unknown dating

Outcomes

Primary Outcomes

CMD presence

Time Frame: A single exam for each participent. The photos will be reviewed within up to 6 month from examination date

Study Sites (1)

Loading locations...

Similar Trials